FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011122975> ?p ?o ?g. }

• W2011122975 endingPage "97" @default.
• W2011122975 startingPage "88" @default.
• W2011122975 abstract "It is well recognized that amounts of trans and saturated fats should be minimized in Western diets; however, considerable debate remains regarding optimal amounts of dietary n-9, n-6, and n-3 fatty acids.The objective was to examine the effects of varying n-9, n-6, and longer-chain n-3 fatty acid composition on markers of coronary heart disease (CHD) risk.A randomized, double-blind, 5-period, crossover design was used. Each 4-wk treatment period was separated by 4-wk washout intervals. Volunteers with abdominal obesity consumed each of 5 identical weight-maintaining, fixed-composition diets with one of the following treatment oils (60 g/3000 kcal) in beverages: 1) conventional canola oil (Canola; n-9 rich), 2) high-oleic acid canola oil with docosahexaenoic acid (CanolaDHA; n-9 and n-3 rich), 3) a blend of corn and safflower oil (25:75) (CornSaff; n-6 rich), 4) a blend of flax and safflower oils (60:40) (FlaxSaff; n-6 and short-chain n-3 rich), or 5) high-oleic acid canola oil (CanolaOleic; highest in n-9).One hundred thirty individuals completed the trial. At endpoint, total cholesterol (TC) was lowest after the FlaxSaff phase (P < 0.05 compared with Canola and CanolaDHA) and highest after the CanolaDHA phase (P < 0.05 compared with CornSaff, FlaxSaff, and CanolaOleic). Low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol were highest, and triglycerides were lowest, after CanolaDHA (P < 0.05 compared with the other diets). All diets decreased TC and LDL cholesterol from baseline to treatment endpoint (P < 0.05). CanolaDHA was the only diet that increased HDL cholesterol from baseline (3.5 ± 1.8%; P < 0.05) and produced the greatest reduction in triglycerides (-20.7 ± 3.8%; P < 0.001) and in systolic blood pressure (-3.3 ± 0.8%; P < 0.001) compared with the other diets (P < 0.05). Percentage reductions in Framingham 10-y CHD risk scores (FRS) from baseline were greatest after CanolaDHA (-19.0 ± 3.1%; P < 0.001) than after other treatments (P < 0.05).Consumption of CanolaDHA, a novel DHA-rich canola oil, improves HDL cholesterol, triglycerides, and blood pressure, thereby reducing FRS compared with other oils varying in unsaturated fatty acid composition. This trial was registered at www.clinicaltrials.gov as NCT01351012." @default.
• W2011122975 created "2016-06-24" @default.
• W2011122975 creator A5001176785 @default.
• W2011122975 creator A5002068723 @default.
• W2011122975 creator A5007855604 @default.
• W2011122975 creator A5016257333 @default.
• W2011122975 creator A5044045965 @default.
• W2011122975 creator A5048490438 @default.
• W2011122975 creator A5055060910 @default.
• W2011122975 creator A5061536717 @default.
• W2011122975 creator A5065460631 @default.
• W2011122975 creator A5077647909 @default.
• W2011122975 creator A5078144573 @default.
• W2011122975 creator A5079154529 @default.
• W2011122975 creator A5086605329 @default.
• W2011122975 creator A5087425230 @default.
• W2011122975 date "2014-05-14" @default.
• W2011122975 modified "2023-10-17" @default.
• W2011122975 title "DHA-enriched high–oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial" @default.
• W2011122975 cites W1588989558 @default.
• W2011122975 cites W174675987 @default.
• W2011122975 cites W1926170255 @default.
• W2011122975 cites W1939555998 @default.
• W2011122975 cites W1967305160 @default.
• W2011122975 cites W2001041291 @default.
• W2011122975 cites W2001744642 @default.
• W2011122975 cites W2017602185 @default.
• W2011122975 cites W2022982788 @default.
• W2011122975 cites W2035206687 @default.
• W2011122975 cites W2046376218 @default.
• W2011122975 cites W2049130601 @default.
• W2011122975 cites W2071137319 @default.
• W2011122975 cites W2073853461 @default.
• W2011122975 cites W2086828863 @default.
• W2011122975 cites W2099556011 @default.
• W2011122975 cites W2102323857 @default.
• W2011122975 cites W2105206504 @default.
• W2011122975 cites W2105953302 @default.
• W2011122975 cites W2109811617 @default.
• W2011122975 cites W2116404316 @default.
• W2011122975 cites W2117191092 @default.
• W2011122975 cites W2128770126 @default.
• W2011122975 cites W2128858609 @default.
• W2011122975 cites W2129241344 @default.
• W2011122975 cites W2132377393 @default.
• W2011122975 cites W2134436172 @default.
• W2011122975 cites W2138013532 @default.
• W2011122975 cites W2139294000 @default.
• W2011122975 cites W2142989164 @default.
• W2011122975 cites W2145813488 @default.
• W2011122975 cites W2148516429 @default.
• W2011122975 cites W2161970713 @default.
• W2011122975 cites W2163519808 @default.
• W2011122975 cites W2165605025 @default.
• W2011122975 cites W2167851640 @default.
• W2011122975 cites W2169562398 @default.
• W2011122975 cites W2170830379 @default.
• W2011122975 cites W2300575801 @default.
• W2011122975 cites W4236225985 @default.
• W2011122975 cites W4239678412 @default.
• W2011122975 cites W4302061855 @default.
• W2011122975 doi "https://doi.org/10.3945/ajcn.113.081133" @default.
• W2011122975 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4144116" @default.
• W2011122975 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24829493" @default.
• W2011122975 hasPublicationYear "2014" @default.
• W2011122975 type Work @default.
• W2011122975 sameAs 2011122975 @default.
• W2011122975 citedByCount "88" @default.
• W2011122975 countsByYear W20111229752013 @default.
• W2011122975 countsByYear W20111229752014 @default.
• W2011122975 countsByYear W20111229752015 @default.
• W2011122975 countsByYear W20111229752016 @default.
• W2011122975 countsByYear W20111229752017 @default.
• W2011122975 countsByYear W20111229752018 @default.
• W2011122975 countsByYear W20111229752019 @default.
• W2011122975 countsByYear W20111229752020 @default.
• W2011122975 countsByYear W20111229752021 @default.
• W2011122975 countsByYear W20111229752022 @default.
• W2011122975 countsByYear W20111229752023 @default.
• W2011122975 crossrefType "journal-article" @default.
• W2011122975 hasAuthorship W2011122975A5001176785 @default.
• W2011122975 hasAuthorship W2011122975A5002068723 @default.
• W2011122975 hasAuthorship W2011122975A5007855604 @default.
• W2011122975 hasAuthorship W2011122975A5016257333 @default.
• W2011122975 hasAuthorship W2011122975A5044045965 @default.
• W2011122975 hasAuthorship W2011122975A5048490438 @default.
• W2011122975 hasAuthorship W2011122975A5055060910 @default.
• W2011122975 hasAuthorship W2011122975A5061536717 @default.
• W2011122975 hasAuthorship W2011122975A5065460631 @default.
• W2011122975 hasAuthorship W2011122975A5077647909 @default.
• W2011122975 hasAuthorship W2011122975A5078144573 @default.
• W2011122975 hasAuthorship W2011122975A5079154529 @default.
• W2011122975 hasAuthorship W2011122975A5086605329 @default.
• W2011122975 hasAuthorship W2011122975A5087425230 @default.
• W2011122975 hasBestOaLocation W20111229751 @default.
• W2011122975 hasConcept C140793950 @default.
• W2011122975 hasConcept C142724271 @default.
• W2011122975 hasConcept C185592680 @default.

• next